# Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer

> **NCT02124681** · PHASE1 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 34 (actual)

## Conditions studied

- Insulin Resistance

## Interventions

- **DRUG:** Hydroxychloroquine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02124681
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02124681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02124681, "Rediscovering Hydroxychloroquine as a Novel Insulin Sensitizer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02124681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*